Dupont Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Dupont Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-50,612	Closed	-$2.35M	–	1324
2019 Q2	$2.35M	Buy	50,612 +13,868	+38%	+$389K	0.05%	338
2019 Q1	$896K	Hold	36,744	–	–	0.02%	580
2018 Q4	$524K	Sell	36,744 -44,326	-55%	-$672K	0.01%	710
2018 Q3	$1.23M	Hold	81,070	–	–	0.03%	513
2018 Q2	$1.36M	Buy	81,070 +27,377	+51%	+$435K	0.03%	466
2018 Q1	$876K	Hold	53,693	–	–	0.02%	547
2017 Q4	$687K	Buy	53,693 +8,987	+20%	+$102K	0.02%	591
2017 Q3	$550K	Buy	+44,706	New	+$415K	0.01%	658

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Dupont Capital Management's ARRY Position: Q3 2019 in Review

Dupont Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 50,612 shares — an estimated $2.35M sold.

Dupont Capital Management first reported a position in ARRY in Q3 2017 and held it in 8 quarters. The position peaked at $2.35M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Dupont Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Dupont Capital Management sold 50,612 Array Biopharma Inc shares in Q3 2019, an estimated $2.35M.
Dupont Capital Management first reported a position in Array Biopharma Inc in Q3 2017 and held it in 8 quarters.
Dupont Capital Management's Array Biopharma Inc position peaked at $2.35M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Dupont Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.